|
Saniona’s drug research is conducted primarily in three ways:
|
|
|
● Through its own drug discovery and development at an early stage. |
|
|
● Through cooperation with major pharmaceutical companies |
|
|
● Through Joint Ventures. |
|
|
From the collaborations Saniona may receive payments in the form of research payments, milestone payments and royalties on marketed products.
Saniona has ongoing collaboration agreements with:
|
|
|
● BenevolentAI |
|
|
● Boehringer Ingelheim GmbH |
|
|
● Cadent Therapeutics |
|
|
● Productos Medix, S.A de S.V |
|
|
● The Michael J. Fox Foundation for Parkinson’s Research |
|
|
● The Treatment Research Center (TRC), University of Pennsylvania |
|